secwatch.observer — SEC 8-K summary
======================================

Issuer:     ULTRALIFE CORP (ULBI)
CIK:        0000875657
Form:       8-K
Filed at:   2025-05-09T23:59:59+00:00
Accession:  0001437749-25-015629
Event type: earnings
Sentiment:  neutral
Materiality: 0.65
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Ultralife Q1 revenue $50.7M (+21% YoY); GAAP EPS $0.11 vs $0.18
---------------------------------------------------------------

- Revenue $50.7M, up 21% YoY; Battery & Energy Products +32.4% to $46.3M (incl. Electrochem, organic +10.6%).
- GAAP EPS $0.11 vs $0.18 YoY; adjusted EPS $0.13 vs $0.21; operating income $3.4M vs $4.1M.
- Gross margin 25.1% (vs 27.4% YoY) on product mix; Communications Systems sales fell 36.2% to $4.4M.
- Backlog $95.0M vs $102.2M at Q4 2024; company cites strong replenishment and tariff mitigation plan.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/875657/000143774925015629/0001437749-25-015629-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/875657/000143774925015629/ulbi20250508_8k.htm
  HTML page:      https://secwatch.observer/filing/0001437749-25-015629

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer